[go: up one dir, main page]

ZA200109420B - Novel crystalline forms of a macrolide antibiotic. - Google Patents

Novel crystalline forms of a macrolide antibiotic.

Info

Publication number
ZA200109420B
ZA200109420B ZA200109420A ZA200109420A ZA200109420B ZA 200109420 B ZA200109420 B ZA 200109420B ZA 200109420 A ZA200109420 A ZA 200109420A ZA 200109420 A ZA200109420 A ZA 200109420A ZA 200109420 B ZA200109420 B ZA 200109420B
Authority
ZA
South Africa
Prior art keywords
crystalline forms
novel crystalline
macrolide antibiotic
macrolide
antibiotic
Prior art date
Application number
ZA200109420A
Other languages
English (en)
Inventor
Robert John Rafka
Douglas John Meldrum Allen
Colman Brendan Ragan
Barry James Morton
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of ZA200109420B publication Critical patent/ZA200109420B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ZA200109420A 1999-05-18 2001-11-15 Novel crystalline forms of a macrolide antibiotic. ZA200109420B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13464499P 1999-05-18 1999-05-18

Publications (1)

Publication Number Publication Date
ZA200109420B true ZA200109420B (en) 2002-11-15

Family

ID=22464300

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200109420A ZA200109420B (en) 1999-05-18 2001-11-15 Novel crystalline forms of a macrolide antibiotic.

Country Status (43)

Country Link
US (1) US6583274B1 (xx)
EP (1) EP1189912B1 (xx)
JP (1) JP3897983B2 (xx)
KR (1) KR100474229B1 (xx)
CN (1) CN1203084C (xx)
AP (1) AP2001002325A0 (xx)
AR (1) AR020030A1 (xx)
AT (1) ATE392427T1 (xx)
AU (1) AU772283B2 (xx)
BG (1) BG106150A (xx)
BR (1) BR0011300A (xx)
CA (1) CA2372206C (xx)
CZ (1) CZ20014120A3 (xx)
DE (1) DE60038610T2 (xx)
DK (1) DK1189912T3 (xx)
DZ (1) DZ3043A1 (xx)
EA (1) EA003417B1 (xx)
ES (1) ES2302689T3 (xx)
GT (1) GT200000072A (xx)
HK (1) HK1045521B (xx)
HN (1) HN2000000056A (xx)
HR (1) HRP20010849A2 (xx)
HU (1) HUP0201341A3 (xx)
IL (2) IL145946A0 (xx)
IS (1) IS6127A (xx)
MA (1) MA26735A1 (xx)
MX (1) MXPA01011914A (xx)
MY (1) MY133397A (xx)
NO (1) NO320195B1 (xx)
NZ (1) NZ514765A (xx)
OA (1) OA11876A (xx)
PA (1) PA8495001A1 (xx)
PE (1) PE20010151A1 (xx)
PL (1) PL353316A1 (xx)
PT (1) PT1189912E (xx)
SK (1) SK16472001A3 (xx)
TN (1) TNSN00103A1 (xx)
TW (1) TWI225066B (xx)
UA (1) UA67842C2 (xx)
UY (1) UY26144A1 (xx)
WO (1) WO2000069874A1 (xx)
YU (1) YU76601A (xx)
ZA (1) ZA200109420B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465437B1 (en) * 1999-06-30 2002-10-15 Pfizer Inc. Diphosphate salt of a 4″-substituted-9-deoxo-9A-AZA-9A- homoerythromycin derivative and its pharmaceutical composition
DE60003586T2 (de) 2000-01-27 2004-01-08 Pfizer Products Inc., Groton Antibiotische azalid-zusammensetzungen
EP1383780A1 (en) * 2001-04-27 2004-01-28 Pfizer Products Inc. Process for preparing 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
EP1435359A1 (en) * 2002-12-31 2004-07-07 Alembic Limited A process for the purification of roxithromycin
US7384921B2 (en) * 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
CA2748847A1 (en) * 2009-01-30 2010-08-05 Glaxo Group Limited Anti-inflammatory macrolide
EP2402355A1 (en) * 2010-07-01 2012-01-04 Novartis AG Crystalline anhydrous forms II and III of Tulathromycin
EP2736915A1 (en) 2011-07-27 2014-06-04 Farma GRS, d.o.o. New crystalline forms of tulathromycin
CN106008622A (zh) * 2016-08-02 2016-10-12 海门慧聚药业有限公司 泰拉霉素新晶型及其制备
CN109942652B (zh) * 2017-12-21 2022-04-26 洛阳惠中兽药有限公司 一种莱柯霉素晶型ⅰ及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RO107257B1 (ro) * 1987-07-09 1993-10-30 Pfizer Procedeu de obtinere a unui dihidrat de azitromicina, cristalin
US5441939A (en) * 1994-03-04 1995-08-15 Pfizer Inc. 3"-desmethoxy derivatives of erythromycin and azithromycin
US5844105A (en) * 1996-07-29 1998-12-01 Abbott Laboratories Preparation of crystal form II of clarithromycin
HN1998000086A (es) * 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.

Also Published As

Publication number Publication date
BG106150A (bg) 2002-05-31
PE20010151A1 (es) 2001-02-08
CN1351607A (zh) 2002-05-29
SK16472001A3 (sk) 2003-02-04
WO2000069874A1 (en) 2000-11-23
ES2302689T3 (es) 2008-08-01
EP1189912A1 (en) 2002-03-27
AP2001002325A0 (en) 2001-12-31
HUP0201341A3 (en) 2003-03-28
US6583274B1 (en) 2003-06-24
CA2372206C (en) 2006-01-10
HUP0201341A2 (en) 2002-08-28
NZ514765A (en) 2004-05-28
DE60038610T2 (de) 2009-06-25
IL145946A (en) 2007-06-17
TNSN00103A1 (fr) 2005-11-10
DK1189912T3 (da) 2008-06-30
UY26144A1 (es) 2000-12-29
TWI225066B (en) 2004-12-11
JP3897983B2 (ja) 2007-03-28
PT1189912E (pt) 2008-05-16
MXPA01011914A (es) 2002-05-06
MY133397A (en) 2007-11-30
JP2002544283A (ja) 2002-12-24
PA8495001A1 (es) 2002-02-21
HN2000000056A (es) 2001-02-02
NO320195B1 (no) 2005-11-14
UA67842C2 (uk) 2004-07-15
EA003417B1 (ru) 2003-04-24
DE60038610D1 (de) 2008-05-29
CN1203084C (zh) 2005-05-25
YU76601A (sh) 2004-09-03
OA11876A (en) 2006-03-27
CZ20014120A3 (cs) 2003-01-15
PL353316A1 (en) 2003-11-17
EA200100984A1 (ru) 2002-06-27
NO20015598L (no) 2002-01-08
AU772283B2 (en) 2004-04-22
IL145946A0 (en) 2002-07-25
AU3572900A (en) 2000-12-05
DZ3043A1 (fr) 2004-03-27
KR20020007415A (ko) 2002-01-26
AR020030A1 (es) 2002-03-27
GT200000072A (es) 2001-11-08
IS6127A (is) 2001-10-26
KR100474229B1 (ko) 2005-03-08
HRP20010849A2 (en) 2003-04-30
ATE392427T1 (de) 2008-05-15
HK1045521B (zh) 2005-12-09
BR0011300A (pt) 2002-02-26
MA26735A1 (fr) 2004-12-20
CA2372206A1 (en) 2000-11-23
NO20015598D0 (no) 2001-11-16
HK1045521A1 (en) 2002-11-29
EP1189912B1 (en) 2008-04-16

Similar Documents

Publication Publication Date Title
EP1363925B8 (en) Macrolide antibiotics
AU2002217277A1 (en) Macrolide antibiotics
AU2001272719A1 (en) Macrolide antibiotics
AU2754700A (en) Busy-wait-free synchronization
AU4847500A (en) Highly crystalline eaodm interpolymers
AP9801421A0 (en) Novel erythromycin derivatives
PL348114A1 (en) Novel macrolide antibiotics
ZA200110413B (en) Crystalline 1-methylcarbapenem compounds.
ZA985655B (en) Crystalline macrolides
IL145256A0 (en) Erythromycin derivatives
ZA200109420B (en) Novel crystalline forms of a macrolide antibiotic.
PL345221A1 (en) Crystalline efavirenz
AU2002230386A1 (en) Sixteen-membered macrolide compounds
AU1161500A (en) Macrolide intermediates
AU6183800A (en) Erythromycin a derivatives
AU6316400A (en) Erythromycin a derivatives
AU2001238020A1 (en) Glycopeptide derivatives having antibiotic activity
AU2694300A (en) Water-absorption-controlling-function knitting
AUPQ765300A0 (en) Novel antibiotic compounds
EP1200083A4 (en) ANTIBIOTIC COMPOUND
AU4942800A (en) Novel amorphous form of clarithromycin
EP1201677A4 (en) NEW JK MACROLIDE COMPOUND
HK1062443A (en) Macrolide antibiotics
AU5806101A (en) Novel antibiotic compounds
AU2001263789A1 (en) Crystalline alkycycline derivative